SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001628280-23-011846
Filing Date
2023-04-18
Accepted
2023-04-18 07:59:19
Documents
21

Document Format Files

Seq Description Document Type Size
1 PRE 14A cccc-20230418.htm   iXBRL PRE 14A 832664
6 cccc-20230418_g1.jpg GRAPHIC 50977
7 cccc-20230418_g2.jpg GRAPHIC 30489
8 cccc-20230418_g3.jpg GRAPHIC 45283
9 cccc-20230418_g4.jpg GRAPHIC 46300
10 cccc-20230418_g5.jpg GRAPHIC 107264
11 cccc-20230418_g6.jpg GRAPHIC 95135
12 cccc-20230418_g7.jpg GRAPHIC 25403
  Complete submission text file 0001628280-23-011846.txt   2308820

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20230418.xsd EX-101.SCH 3365
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cccc-20230418_def.xml EX-101.DEF 4323
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20230418_lab.xml EX-101.LAB 5957
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20230418_pre.xml EX-101.PRE 3328
15 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20230418_htm.xml XML 106529
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39567 | Film No.: 23825516
SIC: 2836 Biological Products, (No Diagnostic Substances)